XML 42 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Information (Unaudited)
 12 Months Ended
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information (Unaudited)
Quarterly Financial Information (Unaudited)
The following tables include a summary of certain information related to the Company's quarterly consolidated results of operations for each of the four quarters in the years ended December 31, 2017 and 2016. The timing of acquisitions and divestitures completed during the years presented affects the comparability of the quarterly financial information. The following should be read in conjunction with the audited consolidated financial statements included herein. The amounts are as follows (in thousands except per share amounts):
 
 
2017
 
 
Predecessor
 
 
 
Successor
 
 
Q1
 
Q2
 
Q3(1)
 
 
 
Q3(1)
 
Q4
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
286,183

 
$
288,353

 
$
174,079

 
 
 
$
132,258

 
$
460,346

Cost of revenues
 
$
211,948

 
$
216,452

 
$
143,772

 
 
 
$
102,924

 
$
338,704

Net income (loss)
 
$
14,422

 
$
11,627

 
$
4,369

 
 
 
$
(2,648
)
 
$
966

Net income attributable to non-controlling interests
 
$
(17,176
)
 
$
(16,098
)
 
$
(8,813
)
 
 
 
$
(6,492
)
 
$
(33,142
)
Net loss attributable to Surgery Partners, Inc.
 
$
(2,754
)
  
$
(4,471
)
 
$
(4,444
)
 
 
 
$
(9,140
)
 
$
(32,176
)
Basic net loss per share attributable to common stockholders (2)
 
$
(0.06
)
 
$
(0.09
)
 
$
(0.09
)
 
 
 
$
(0.57
)
 
$
(0.83
)
Diluted net loss per share attributable to common stockholders (2)
 
$
(0.06
)
 
$
(0.09
)
 
$
(0.09
)
 
 
 
$
(0.57
)
 
$
(0.83
)
(1) The Predecessor period for Q3 includes the two months ended August 31, 2017. The Successor period for Q3 includes the one month ended September 30, 2017.
(2) Beginning in the Successor period, per share amounts include the impact of amounts allocated to participating securities. Refer to Note 10. "Earnings Per Share" for further discussion.
 
 
2016
 
 
Predecessor
 
 
Q1
 
Q2
 
Q3
 
Q4
 
 
 
 
 
 
 
 
 
Revenues
 
$
267,074

 
$
289,681

 
$
282,682

 
$
306,001

Cost of revenues
 
$
196,703

 
$
208,852

 
$
201,394

 
$
214,247

Net income
 
$
10,357

 
$
22,293

 
$
14,334

 
$
38,100

Net income attributable to non-controlling interests
 
$
(17,547
)
 
$
(20,173
)
 
$
(16,672
)
 
$
(21,238
)
Net (loss) income attributable to Surgery Partners, Inc.
 
$
(7,190
)
  
$
2,120

 
$
(2,338
)
 
$
16,862

Basic net (loss) income per share attributable to common stockholders
 
$
(0.15
)
 
$
0.04

 
$
(0.05
)
 
$
0.35

Diluted net (loss) income per share attributable to common stockholders
 
$
(0.15
)
 
$
0.04

 
$
(0.05
)
 
$
0.35